Utah Medical Products, Inc. Financial Ratios — UTMD Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	18.88	22.17	20.45	18.18	17.65	17.46	11.54	22.21	15.5	10.59	14.09	14.88	13.72	11.29	9.54
Return on Assets (%)	12.61	13.26	14.47	14.07	14.78	15.61	10.07	19.28	14.06	9.75	13.01	13.76	12.83	10.76	9.21
Return on Capital (%)	15.77	16.81	17.58	16.66	17.1	17.46	11.54	22.21	15.46	10.55	14.04	14.83	13.68	11.27	9.52
Return on Invested Capital (%)	15.47	16.5	17.14	16.33	16.66	16.92	11.34	21.07	15.14	10.43	13.9	14.18	11.39	9.11	7.72
Gross Margin (%)	59.17	60.9	59.94	60.52	60.23	60.28	63.73	62.64	62.82	60.57	63.03	61.58	59.81	59.03	57.12
EBITDA Margin (%)	38.6	44.43	44.51	47.38	46.81	48.4	52.6	51.56	52.26	49.59	53.34	51.4	46.08	40.19	37.41
Operating Margin (%)	31.28	36.57	36.62	39.25	38.97	41.19	45.9	44.52	37.59	32.5	38.49	37.85	33.4	33.23	29.6
Incremental Operating Margin (%)	22.93	90.85	34.75	175.03	49.15	-62.4	133.46	-53.77	-21.71	83.03	75.22	28.2	146.48	34.15	91.98
Pretax Margin (%)	29.27	34.99	35.75	38.31	38.71	41.79	46.08	46.33	38.13	32.81	38.86	39.52	40	41.08	36.63
Profit Margin (%)	19.58	24.47	28.17	27.56	29.49	30.86	20.54	44.18	31.4	25.6	30.15	31.51	33.12	33.92	29.3
Net Income to Common Margin (%)	19.58	24.47	28.17	27.56	29.49	30.86	20.54	44.18	31.4	25.6	30.15	31.51	33.12	33.92	29.3
Effective Tax Rate (%)	33.09	30.05	21.21	28.04	23.81	26.15	55.43	4.65	17.65	21.98	22.42	20.26	17.19	17.43	20.01
Dvd Payout Ratio (%)	46.3	34.96	32.22	33.09	32.47	32.29	34.74	21.7	27.92	38.12	77.53	19.2	25.74	30.7	35.29
Sustainable Growth Rate (%)	10.14	14.42	13.86	12.17	11.92	11.83	7.53	17.39	11.17	6.55	3.17	12.02	10.19	7.82	6.17

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	22	13	9	5	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
ST Debt	5	4	4	4	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
LT Debt	16	9	5	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/EBITDA	1.48	0.7	0.51	0.25	- -	- -	- -	- -	0.02	0.02	0.02	0.01	0.01	0.02	0.02
Net Debt/EBITDA	1.04	0.22	-0.29	-0.74	-1.24	-1.38	-1.83	-2.36	-1.75	-2.47	-2.33	-2.79	-4.01	-5.05	-5.95
Total Debt/EBIT	1.83	0.86	0.61	0.3	- -	- -	- -	- -	0.02	0.02	0.02	0.02	0.02	0.02	0.02
Net Debt/EBIT	1.28	0.27	-0.36	-0.89	-1.49	-1.62	-2.1	-2.73	-2.43	-3.76	-3.23	-3.79	-5.54	-6.1	-7.52
EBITDA to Interest Expense	17.01	28.32	41.15	67.67	289.2	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	16.71	27.92	40.36	63.76	285.42	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	13.79	23.31	33.85	56.06	240.78	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	1	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	53.35	66.25	75.06	79.62	87.97	90.88	84.23	89.2	92.08	92.01	92.65	92.23	94.73	95.83	97.33
Long-Term Debt/Equity (%)	39.85	17.66	8.36	1.51	- -	- -	- -	- -	0.37	0.33	0.37	0.3	0.23	0.24	0.19
Long-Term Debt/Capital (%)	26.02	14.07	7.27	1.4	- -	- -	- -	- -	0.37	0.32	0.37	0.3	0.23	0.24	0.19
Long-Term Debt/Total Assets (%)	21.26	11.7	6.28	1.2	- -	- -	- -	- -	0.34	0.3	0.34	0.28	0.22	0.23	0.18
Total Debt/Equity (%)	53.18	25.51	15.05	7.54	- -	- -	- -	- -	0.37	0.33	0.37	0.3	0.23	0.24	0.19
Total Debt/Capital (%)	34.72	20.33	13.08	7.01	- -	- -	- -	- -	0.37	0.32	0.37	0.3	0.23	0.24	0.19
Total Debt/Total Assets (%)	28.37	16.9	11.3	6	- -	- -	- -	- -	0.34	0.3	0.34	0.28	0.22	0.23	0.18
Net Debt to Equity	37.14	8.11	-8.71	-22.32	-33.42	-37.98	-51.04	-57.43	-42.32	-50.17	-56.91	-65.69	-72.38	-70.66	-71.9
Net Debt/Capital (%)	27.08	7.5	-9.54	-28.73	-50.2	-61.23	-104.26	-134.93	-72.91	-100.04	-130.96	-189.8	-259.84	-238.9	-254.19
EBITDA	15	18	18	20	19	19	22	22	25	21	26	27	23	16	14
EBITDA-CapEx	14	18	18	18	19	16	20	21	3	20	26	26	23	16	14
Operating Income (Loss)	12	15	15	16	16	16	19	19	18	14	19	20	17	14	11

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.69	1.14	1.9	2.15	5.74	8.72	7.57	9.72	12.41	13.61	16.28	12.59	19.72	22.09	33.01
Current Ratio	1.77	2.37	3.19	3.31	8.08	11.41	9.32	11.58	15.92	16.42	19.53	15.09	22.56	25.64	37.62
Quick Ratio	1.18	1.69	2.47	2.68	6.86	9.79	8.25	10.47	13.78	14.69	17.65	13.52	20.44	23.18	34.36
CFO/Avg Current Liab	1.97	1.55	1.59	1.86	2.12	4.1	4.07	3.19	3.92	5.56	5.63	4.36	4.18	3.5	4.62
Common Equity/Total Assets	53.35	66.25	75.06	79.62	87.97	90.88	84.23	89.2	92.08	92.01	92.65	92.23	94.73	95.83	97.33
Long-Term Debt/Equity (%)	39.85	17.66	8.36	1.51	- -	- -	- -	- -	0.37	0.33	0.37	0.3	0.23	0.24	0.19
Long-Term Debt/Capital (%)	26.02	14.07	7.27	1.4	- -	- -	- -	- -	0.37	0.32	0.37	0.3	0.23	0.24	0.19
Long-Term Debt/Total Assets (%)	21.26	11.7	6.28	1.2	- -	- -	- -	- -	0.34	0.3	0.34	0.28	0.22	0.23	0.18
Total Debt/Equity (%)	53.18	25.51	15.05	7.54	- -	- -	- -	- -	0.37	0.33	0.37	0.3	0.23	0.24	0.19
Total Debt/Capital (%)	34.72	20.33	13.08	7.01	- -	- -	- -	- -	0.37	0.32	0.37	0.3	0.23	0.24	0.19
Total Debt/Total Assets (%)	28.37	16.9	11.3	6	- -	- -	- -	- -	0.34	0.3	0.34	0.28	0.22	0.23	0.18
CFO/Total Liabilities	31.89	52.24	61.14	93.14	144.86	209.13	115.63	156.22	196.18	225.68	249.51	219.82	311.84	290.18	448.75
CFO/CapEx	44.22	53.19	35.78	13.59	56.1	4.4	10.59	41.88	0.79	23.42	38.41	26.14	- -	- -	- -
Altman's Z-Score	7.3	9.53	12.19	13.72	19.5	28.82	16.98	21.57	32.62	24.9	30.06	26.69	29.28	27.63	36.12

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	9.77	9.69	10.46	10.66	10.37	11.17	11.83	10.8	10.54	9.31	10.32	9.66	11.13	10.59	9.31
Days Sales Outstanding	37.35	37.66	34.91	34.25	35.19	32.69	30.86	33.79	34.63	39.2	35.38	37.79	32.8	34.48	39.2
Inventory Turnover	3.82	3.47	3.58	3.4	3.52	3.57	3.07	2.95	2.83	2.53	2.83	2.61	2.19	1.82	1.97
Days Inventory Outstanding	95.64	105.13	101.91	107.25	103.61	102.17	118.91	123.93	129	144.16	128.98	140.02	166.32	200.29	185.02
Accounts Payable Turnover	26.26	16.2	18.69	19.35	19.39	20.52	17.09	16.62	18.27	16.9	23.9	22.54	21.09	21.83	19.47
Accounts Payable Turnover Days	13.9	22.53	19.53	18.87	18.83	17.79	21.36	21.97	19.97	21.6	15.27	16.19	17.31	16.72	18.75
Cash Conversion Cycle	119.09	120.26	117.29	122.63	119.98	117.07	128.41	135.76	143.65	161.76	149.09	161.61	181.81	218.05	205.47
Inventory to Cash Days	-58.29	-67.47	-67	-73	-68.42	-69.48	-88.06	-90.14	-94.37	-104.96	-93.59	-102.23	-133.52	-165.82	-145.82
Inventories	5	4	5	5	4	5	5	5	7	6	7	9	10	9	8
Raw Materials	2	2	2	2	2	2	3	3	4	3	4	6	6	5	5
Work In Process	1	1	1	1	1	1	1	1	1	1	1	1	2	1	2
Finished Goods	3	2	1	2	2	1	1	2	2	1	1	2	2	2	1
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	98	133	214	225	220	270	303	309	402	307	366	365	306	205	178
- Cash & Cash Equivalents	7	9	14	19	23	26	40	51	43	52	61	75	93	83	86
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	22	13	9	5	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	113	138	209	211	196	244	263	258	359	256	305	290	213	122	93
Total Capital	62	64	70	69	70	69	78	89	101	103	108	115	129	118	119
Total Debt/Capital (%)	34.72	20.33	13.08	7.01	- -	- -	- -	- -	0.37	0.32	0.37	0.3	0.23	0.24	0.19
Total Debt / EV	0.19	0.09	0.04	0.02	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales	2.99	3.31	5.15	5.1	4.89	6.2	6.35	6.14	7.66	6.07	6.22	5.55	4.24	2.99	2.41
EV/EBITDA	7.76	7.45	11.57	10.77	10.44	12.82	12.07	11.91	14.65	12.23	11.65	10.79	9.21	7.44	6.44
EV/EBIT	9.57	9.05	14.07	13	12.54	15.06	13.83	13.79	20.37	18.66	16.15	14.65	12.7	9	8.14
EV/Cash Flow to Firm	9.49	9.81	16.49	13.5	14.17	16.78	15.55	15.32	21.06	12.71	14.38	13.71	9.57	8.25	6.31
EV/Free Cash Flow to Firm	9.29	9.64	16.05	12.59	13.92	13.67	14.21	14.96	9.31	12.19	14.02	13.21	9.57	8.25	6.31
Diluted Market Cap	98	134	216	227	221	274	304	311	403	310	366	366	306	215	181
Diluted Enterprise Value	114	138	211	212	198	248	264	260	361	258	305	292	214	133	96
EV per Share	31.14	37.15	55.73	56.19	52.32	65.65	70.66	69.34	96.5	70.23	83.43	79.94	58.72	36.68	29.12
TTM Sales	38	42	40	41	40	39	41	42	47	42	49	52	50	41	39
TTM EBITDA	15	18	18	20	19	19	22	22	25	21	26	27	23	16	14
TTM Operating Income	12	15	15	16	16	16	19	19	18	14	19	20	17	14	11
TTM Cash Flow to Firm	12	14	13	16	14	15	17	17	17	20	21	21	22	15	15
TTM Free Cash Flow to Firm	12	14	13	17	14	18	19	17	39	21	22	22	22	15	15

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	8.47	9.68	17.05	13.72	15.72	15.37	16.44	18.07	10.45	14.74	16.82	16.68	13.75	14.52	12.34
EV/EBIT	9.57	9.05	14.07	13	12.54	15.06	13.83	13.79	20.37	18.66	16.15	14.65	12.7	9	8.14
Enterprise Value	113	138	209	211	196	244	263	258	359	256	305	290	213	122	93
Low Price	24.52	26.61	36.18	44.52	50	54.2	58.5	73.98	76.6	75.33	81.01	80.1	75	60.39	51.26
EV/Sales	2.99	3.31	5.15	5.1	4.89	6.2	6.35	6.14	7.66	6.07	6.22	5.55	4.24	2.99	2.41
EV/EBITDA	7.76	7.45	11.57	10.77	10.44	12.82	12.07	11.91	14.65	12.23	11.65	10.79	9.21	7.44	6.44
Price/Earnings	13.26	13.16	18.91	19.92	18.64	22.59	35.58	16.66	27.39	28.44	24.72	22.14	18.38	14.78	15.8
Price/Earnings Average	13.18	11.92	16.52	17.58	18.01	19.58	30.48	18.92	23.27	29.58	22.56	19.65	19.71	16.55	16.33
Price/Earnings High	14.41	13.26	21.46	20.23	20.38	23.29	37.16	23.59	28.49	37.11	33.09	24.12	22.13	20.62	18.51
Price/Earnings Low	12.04	9.71	11.97	14.77	15.92	16.83	25.57	14.83	19.44	25.41	20.02	17.64	16.37	14.52	14.47
Price/Book Value	2.41	2.62	3.53	3.49	3.15	3.9	3.88	3.47	3.97	2.99	3.41	3.19	2.38	1.75	1.49
Price/Book Value Average	2.4	2.37	3.09	3.08	3.05	3.38	3.32	3.95	3.37	3.11	3.11	2.83	2.56	1.95	1.55
Price/Book Value High	2.62	2.64	4.01	3.54	3.45	4.02	4.05	4.92	4.13	3.9	4.57	3.48	2.87	2.44	1.75
Price/Book Value Low	2.19	1.93	2.24	2.58	2.69	2.91	2.79	3.09	2.82	2.67	2.76	2.54	2.12	1.72	1.37
Price/Tangible Book Value	-10.01	133.36	17.14	10.52	7.15	7.2	6.56	5.11	7.06	4.75	4.86	4.03	2.79	2.03	1.71
Price/Tangible Book Value Average	-9.95	120.78	14.97	9.29	6.91	6.25	5.62	5.8	5.99	4.94	4.43	3.57	2.99	2.27	1.77
Price/Tangible Book Value High	-10.89	134.36	19.44	10.69	7.81	7.43	6.85	7.24	7.34	6.2	6.5	4.39	3.36	2.83	2
Price/Tangible Book Value Low	-9.09	98.44	10.85	7.8	6.11	5.37	4.71	4.55	5.01	4.24	3.93	3.21	2.48	1.99	1.56
Price/Sales	2.6	3.22	5.33	5.49	5.5	6.97	7.31	7.36	8.6	7.28	7.45	6.98	6.09	5.01	4.63
Price/Sales Average	2.58	2.92	4.65	4.85	5.31	6.04	6.26	8.36	7.3	7.57	6.8	6.19	6.53	5.61	4.79
Price/Sales High	2.82	3.24	6.04	5.58	6.01	7.19	7.63	10.42	8.95	9.5	9.97	7.6	7.33	6.99	5.42
Price/Sales Low	2.36	2.38	3.37	4.07	4.7	5.19	5.25	6.55	6.1	6.51	6.04	5.56	5.42	4.92	4.24
Price/Cash Flow	8.65	9.86	17.53	14.73	16	18.86	17.9	18.36	23.65	15.25	17.24	17.25	13.72	13.82	12.14
Price/Cash Flow Average	8.6	8.93	15.31	13	15.45	16.35	15.33	20.86	20.09	15.86	15.73	15.3	14.71	15.48	12.55
Price/Cash Flow High	9.4	9.94	19.88	14.96	17.49	19.44	18.69	26	24.6	19.9	23.08	18.79	16.52	19.29	14.22
Price/Cash Flow Low	7.85	7.28	11.09	10.92	13.66	14.05	12.86	16.35	16.79	13.63	13.96	13.74	12.22	13.58	11.12
Price/Free Cash Flow Average	8.42	8.77	14.9	12.11	15.19	13.32	14.08	20.53	8.88	15.33	15.35	14.8	14.74	16.26	12.76
Price/Free Cash Flow High	9.21	9.76	19.35	13.94	17.18	15.84	17.17	25.59	10.88	19.24	22.52	18.17	16.55	20.26	14.46
Price/Free Cash Flow Low	7.69	7.15	10.8	10.17	13.43	11.45	11.81	16.09	7.42	13.17	13.63	13.29	12.24	14.26	11.3
EV/Sales Average	2.98	3.01	4.49	4.46	4.7	5.29	5.3	7.14	6.37	6.36	5.57	4.76	4.68	3.59	2.56
EV/Sales High	3.22	3.34	5.86	5.19	5.4	6.42	6.68	9.2	8	8.28	8.74	6.17	5.49	4.97	3.2
EV/Sales Low	2.76	2.47	3.21	3.69	4.09	4.45	4.29	5.34	5.17	5.29	4.8	4.13	3.58	2.9	2.02
EV/EBITDA Average	7.72	6.77	10.08	9.42	10.05	10.93	10.08	13.85	12.19	12.82	10.43	9.26	10.17	8.93	6.86
EV/EBITDA High	8.35	7.51	13.17	10.95	11.53	13.26	12.69	17.85	15.31	16.71	16.39	12	11.91	12.37	8.56
EV/EBITDA Low	7.14	5.56	7.22	7.79	8.74	9.2	8.16	10.35	9.9	10.67	9	8.03	7.76	7.22	5.4
EV/EBIT Average	9.53	8.23	12.25	11.37	12.07	12.84	11.55	16.04	16.94	19.56	14.46	12.58	14.02	10.8	8.66
EV/EBIT High	10.3	9.12	16.01	13.22	13.85	15.58	14.54	20.67	21.29	25.49	22.71	16.3	16.42	14.96	10.82
EV/EBIT Low	8.82	6.76	8.78	9.41	10.5	10.81	9.35	11.98	13.76	16.28	12.47	10.91	10.71	8.73	6.82
Last Price	27	36.05	57.16	60.05	58.54	72.75	81.4	83.08	107.9	84.3	100	100.53	84.22	61.47	55.96
High Price	29.36	36.32	64.84	61	63.98	75	85	117.65	112.26	109.99	133.87	109.5	101.41	85.76	65.56
Enterprise Value Average	113	125	182	184	189	208	220	300	299	268	273	249	235	147	99
Enterprise Value High	122	139	237	214	217	252	276	387	375	349	429	323	276	203	123
Enterprise Value Low	104	103	130	152	164	175	178	224	243	223	236	216	180	119	78

Shares Outstanding	4	4	4	4	4	4	4	4	4	4	4	4	4	3	3
Diluted Weighted Avg Shares	4	4	4	4	4	4	4	4	4	4	4	4	4	4	3
Basic Weighted Avg Shares	4	4	4	4	4	4	4	4	4	4	4	4	4	3	3
Revenue per Share	10.4	11.2	10.73	10.94	10.65	10.43	11.14	11.29	12.55	11.58	13.42	14.41	13.84	12.26	12.09
EBITDA per Share	4.02	4.97	4.78	5.18	4.98	5.05	5.86	5.82	6.56	5.74	7.16	7.41	6.38	4.93	4.52
Operating Income per Share	3.25	4.09	3.93	4.29	4.15	4.3	5.11	5.03	4.72	3.76	5.17	5.45	4.62	4.08	3.58
Basic EPS, GAAP	2.04	2.74	3.02	3.01	3.14	3.22	2.29	4.99	3.94	2.96	4.05	4.54	4.58	4.16	3.54
Basic EPS from Cont Ops	2.04	2.74	3.02	3.01	3.14	3.22	2.29	4.99	3.94	2.96	4.05	4.54	4.58	4.16	3.54
Diluted EPS, GAAP	2.03	2.74	3.02	3.01	3.14	3.22	2.28	4.95	3.94	2.94	4.04	4.52	4.57	3.96	3.48
Diluted EPS from Cont Ops	2.03	2.74	3.02	3.01	3.14	3.22	2.28	4.95	3.94	2.94	4.04	4.52	4.57	3.96	3.48
Dividend per Share	0.94	0.96	0.97	1	1.02	1.04	0.79	1.08	1.1	1.13	3.14	0.87	1.18	1.28	1.25
Cash Flow per Share	3.12	3.65	3.26	4.08	3.66	3.86	4.55	4.53	4.56	5.53	5.8	5.83	6.14	4.45	4.61
Free Cash Flow per Basic Share	3.05	3.59	3.17	3.78	3.59	2.98	4.12	4.42	-1.2	5.29	5.65	5.61	6.14	4.45	4.61
Cash & Equivalents per Share	1.81	2.41	3.86	5.16	6.22	7.1	10.74	13.74	11.5	14.16	16.68	20.69	25.58	24.88	26.91
Book Value per Share	11.2	13.77	16.19	17.22	18.57	18.65	20.99	23.92	27.16	28.22	29.31	31.49	35.35	35.21	37.43
Tangible Book Value per Share	-2.7	0.27	3.34	5.71	8.19	10.1	12.41	16.26	15.29	17.75	20.6	24.95	30.21	30.28	32.76

Utah Medical Products, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)